Comera Life Sciences Holdings, Inc. (OTCPK: CMRA)
Health Care · Biotechnology · US
$—
— today · — 1Y
Comera Life Sciences Holdings, Inc. (OTCPK: CMRA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.07K and employs 12 people.
trading between 0.00 and 0.00.
Tweenvest scores Comera Life Sciences Holdings, Inc. across four factors: quality 23/100, value 43/100. Its strongest factor is value.
CMRA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.07K
- Revenue (TTM)
- $1.00M
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- -85.10
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 30.74M
- Employees
- 12
- Next earnings
- —
About Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platform, engineered to transform intravenous (IV) biologic drugs into more convenient subcutaneous (SQ) injectable forms. Currently, the company is progressing two main product candidates: CLS-001, an early-stage "biobetter" designed to treat inflammatory bowel conditions like Crohn's and Ulcerative Colitis, and CLS-002, another preclinical biobetter aimed at diverse oncology indications. Established in 2014, Comera Life Sciences is headquartered in Woburn, Massachusetts.
- Founded
- 2014
- Listed since
- Dec 21, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.